Patent ID: 7652036

Claim:
A compound selected from compounds of the following formula and pharmaceutically acceptable salts thereof: wherein: A is an unsubstituted or substituted quinoline; Q is independently a saturated or unsaturated C 1-7 alkylene group having a backbone length of 4 or less; wherein backbone atoms of Q, which link A and —C(═O)NHOH, are denoted α, β, γ, and δ, starting with the backbone atom adjacent to —C(═O)NHOH; wherein Q is unsubstituted or substituted with one or more substituents independently selected from —CONH 2 ,—CONMe 2 , —C(═O)Me, —F, —Cl, —Br, —I, —NO 2 , —OH, —OMe, —OEt, —O(iPr), —NH 2 , —NMe 2 , —NEt 2 , morpholino, —NHCOMe, -Ph, ═O, ═NH, ═NMe, and ═NOH; with the proviso that if A is unsubstituted quinolin-6-yl, then Q is unsubstituted at the α-position.